Results 151 to 160 of about 35,054 (306)

199. Fast Detection of Ceftazidime-avibactam-resistant Enterobacterales with VITEK-MSTM Incorporating a Direct-on-target Microdroplet Growth Assay [PDF]

, 2023
Shenglei haung, Cheng‐Feng Qin, Bingchun Pu, Chunmei Zhou, Yan Ma, Beili Wang, Baishen Pan, Bijie Hu, Wei Guo   +8 more
openalex   +1 more source

In vitro activity assessment of cefiderocol against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp., including β-lactam nonsusceptible molecularly characterized isolates, collected from 2020 to 2021 in the United States and European hospitals

Microbiology spectrum
This study reports the activity of cefiderocol against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp. isolates collected from the United States and Europe, including Israel and Turkey, from 2020 to 2021.
J. Kimbrough, Joshua M. Maher, H. Sader, M. Castanheira, Rodrigo E. Mendes   +4 more
semanticscholar   +1 more source

Susceptibility of carbapenemase-producing Enterobacterales (CPE) to nitroxoline

Journal of Antimicrobial Chemotherapy, 2019
AbstractBackgroundInfections caused by carbapenemase-producing Enterobacterales (CPE) constitute a major global health concern and are associated with increased morbidity and mortality. Nitroxoline is an old antibiotic, which has recently been re-launched for the treatment of uncomplicated urinary tract infection.
Frieder Fuchs, Axel Hamprecht
openaire   +2 more sources

Establishing the reference broth microdilution MIC method for cefepime-taniborbactam

Journal of Clinical Microbiology
The investigational β-lactam/β-lactamase inhibitor combination cefepime-taniborbactam is intended as therapy for serious infections caused by Gram-negative pathogens resistant to third-generation cephalosporins and carbapenems.
Adam Belley, Susan M. Cusick, Dan C. Pevear, Laura Koeth, Jeanna DiFranco-Fisher, Nimmi Kothari, Stephen Hawser, Greg Moeck   +7 more
doaj   +1 more source

Risk factors for antimicrobial-resistant Enterobacterales in dogs: a systematic review

Frontiers in Veterinary Science
Identifying risk factors associated with the carriage of antimicrobial-resistant (AMR) bacteria in dogs is crucial to understanding their epidemiology and for developing and refining targeted control measures.
Esa Karalliu, Kai Yeung Chung, Brett MacKinnon, Belete Haile, P. Bęczkowski, Vanessa R. Barrs, I. Elsohaby, O. Nekouei   +7 more
semanticscholar   +1 more source

In vitro antibacterial activity of tigecycline against multidrug-resistant bacteria isolated at the Sourô Sanou University teaching hospital in Bobo-Dioulasso, Burkina Faso

African Journal of Laboratory Medicine
Background: Tigecycline, an antibiotic effective against multidrug-resistant bacteria (MDRB), remains inaccessible in Burkina Faso’s hospitals for urgent care. Given the resulting therapeutic challenges and mortality in emergency services, evidence-based
Odilon D. Kaboré, Mélissa J. Gonfouli, Merci Muhigwa, Abdourahmane Sow, Fernand Michodigni, André Nagalo, Jacques Zoungrana, Arsène Hema, Augustin Konkobo, Hervé Kafando, Adama Ouattara, Armel Poda, Sylvain Godreuil, Abdoul-Salam Ouedraogo   +13 more
doaj   +1 more source

A Simple Disk Stacking Plus Micro-Elution Method for Rapid Detection of the Synergistic Effect of Aztreonam and Ceftazidime/Avibactam Against Metallo-β-Lactamase Producing Enterobacterales

Infection and Drug Resistance, 2023
Zhou Liu,1,* Xiubing Hang,1,* Tao Yan,1 Wenwen Chu,1 Zhen Gong,1 Yanyan Liu,2– 4 Yuanyuan Dai,5 Min Yang,6 Jiabin Li,2– 4 Qiang Zhou1 1Department of Laboratory Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui,
Liu Z, Hang X, Yan T, Chu W, Gong Z, Liu Y, Dai Y, Yang M, Li J, Zhou Q   +9 more
doaj  

2132. Surveillance of Eravacycline Against Enterobacterales and Non-Fermenter Clinical Isolates, Including Resistant Isolates, Collected Worldwide from Multiple Infection Sites During 2021 [PDF]

, 2023
Stephen Hawser, Nimmi Kothari, Federica Monti, Tony Hodges, Kristie Zappas   +4 more
openalex   +1 more source

Prevalence of carbapenem-resistant Enterobacterales with blaIMP-6 predominance in hospitals from 2018 to 2021 in Nara, Japan

JAC-Antimicrobial Resistance
Objectives Despite the global health risk of carbapenem-resistant Enterobacterales (CRE), especially carbapenemase-producing Enterobacterales (CPE), Japan reports a significantly low frequency of CRE with a predominance of IMP-type carbapenemases.
Rio Kishi, R. Nakano, A. Nakano, Takehito Harimoto, Ryusei Taniguchi, Sayaka Ando, Yuki Suzuki, Koichi Yamaguchi, D. Kitagawa, S. Horiuchi, Kousuke Tsubaki, Ryuichi Morita, Takashi Kawabe, Hisakazu Yano   +13 more
semanticscholar   +1 more source

Oral β-Lactam Antibiotics vs Fluoroquinolones or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Enterobacterales Bacteremia From a Urine Source [PDF]

, 2020
Jesse Sutton, Vanessa Stevens, Nai-Chung Chang, Karim Khader, Tristan T. Timbrook, Emily S Spivak   +5 more
openalex   +1 more source